MCID: ATR003
MIFTS: 29

Atrophic Rhinitis malady

Category: Respiratory diseases

Aliases & Classifications for Atrophic Rhinitis

About this section

Aliases & Descriptions for Atrophic Rhinitis:

Name: Atrophic Rhinitis 10 12
Rhinitis, Atrophic 10 36 65
Rhinitis Sicca 10 65
 
Ozena 10 65
Dry Rhinitis 10
Ozaena 10

Classifications:



External Ids:

Disease Ontology10 DOID:4731
SNOMED-CT59 28111002
MeSH36 D012222
UMLS65 C0035459, C0030105, C0339800

Summaries for Atrophic Rhinitis

About this section
Disease Ontology:10 A rhinitis which involves inflammation of the nose characterised by atrophy of nasal mucosa including the glands, turbinate bones, and the nerve elements supplying the nose that is caused by heredity factors, endocrine imbalance, nutritional deficiency, bacterial infection and autoimmune issues.

MalaCards based summary: Atrophic Rhinitis, also known as rhinitis, atrophic, is related to actinobacillosis and endotheliitis. An important gene associated with Atrophic Rhinitis is XPNPEP2 (X-Prolyl Aminopeptidase (Aminopeptidase P) 2, Membrane-Bound). Affiliated tissues include bone, breast and thyroid.

Related Diseases for Atrophic Rhinitis

About this section

Graphical network of the top 20 diseases related to Atrophic Rhinitis:



Diseases related to atrophic rhinitis

Symptoms for Atrophic Rhinitis

About this section

Drugs & Therapeutics for Atrophic Rhinitis

About this section

Drugs for Atrophic Rhinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 10)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
AcetylcholineexperimentalPhase 1, Phase 268951-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
Miochol E
O-Acetylcholine
acetylcholine chloride
2Neurotransmitter AgentsPhase 1, Phase 214795
3OnabotulinumtoxinAPhase 1, Phase 2588
4Peripheral Nervous System AgentsPhase 1, Phase 218510
5Neuromuscular AgentsPhase 1, Phase 2922
6Cholinergic AgentsPhase 1, Phase 23243
7Botulinum ToxinsPhase 1, Phase 2616
8Botulinum Toxins, Type APhase 1, Phase 2588
9AbobotulinumtoxinAPhase 1, Phase 2588
10IncobotulinumtoxinAPhase 1, Phase 2599

Interventional clinical trials:

idNameStatusNCT IDPhase
1Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome SyndromeTerminatedNCT00732680Phase 1, Phase 2
2Gore Tex Implants in the Treatment of Atrophic RhinitisSuspendedNCT00832403
3Topical Antibiotic Use In Chronic Rhinosinusitis A Double-Blinded, Randomized, Placebo Controlled StudyWithdrawnNCT00669799

Search NIH Clinical Center for Atrophic Rhinitis


Cochrane evidence based reviews: rhinitis, atrophic

Genetic Tests for Atrophic Rhinitis

About this section

Anatomical Context for Atrophic Rhinitis

About this section

MalaCards organs/tissues related to Atrophic Rhinitis:

33
Bone, Breast, Thyroid, Prostate, Pituitary, Liver, Testes

Animal Models for Atrophic Rhinitis or affiliated genes

About this section

Publications for Atrophic Rhinitis

About this section

Articles related to Atrophic Rhinitis:

(show top 50)    (show all 371)
idTitleAuthorsYear
1
Recent Updates on the Treatment of Constipation. (26576134)
2015
2
Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. (23334332)
2014
3
Pathogenic variants in TUBB4A are not found in primary dystonia. (24598712)
2014
4
Hydrogen sulfide promotes proliferation and neuronal differentiation of neural stem cells and protects hypoxia-induced decrease in hippocampal neurogenesis. (24246910)
2014
5
Porphyria cutanea tarda and spherocytosis: a non-random association? (23093332)
2013
6
Outcomes in critically ill cancer patients with septic shock of pulmonary origin. (23364436)
2013
7
Risk factors for "PTH spikes" during surgery for primary hyperparathyroidism. (23828733)
2013
8
Visfatin levels in Behcet's disease. (21494798)
2012
9
Dynamic abdominoplasty for the treatment of prune belly syndrome. (22929250)
2012
10
A case of autoimmune pancreatitis showing narrowing of the main pancreatic duct after cessation of steroid therapy in the clinical course. (22892491)
2012
11
Surgical management of carcinoid heart valve disease. (23465673)
2012
12
Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients. (19302404)
2010
13
NF-kappaB expression predicts clinical outcome for nasal polyposis. (21442076)
2010
14
Involvement of the MEKK1 signaling pathway in the regulation of epicardial cell behavior by hyaluronan. (20159036)
2010
15
Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4. (20492653)
2010
16
Thrombin generation testing in haemophilia comprehensive care centres. (19719549)
2010
17
Lymphoid neoplasms of the urinary tract and male genital organs: a clinicopathological study of 40 cases. (19377442)
2009
18
Case report and review: epicardial coronary artery fibromuscular dysplasia. (18242135)
2009
19
A dual-acceptor time-resolved FAPster resonance energy transfer assay for simultaneous determination of thyroid hormone regulation of corepressor and coactivator binding to the thyroid hormone receptor: Mimicking the cellular context of thyroid hormone action. (19111515)
2009
20
A phase I trial of PTK787/ZK222584 in combination with pemetrexed and cisplatin in patients with advanced solid tumors. (18641920)
2009
21
Adhesive dynamics simulations of the mechanical shedding of L-selectin from the neutrophil surface. (19486904)
2009
22
A complication of Roux-en-Y gastric bypass: intestinal obstruction. (17891439)
2007
23
The xenobiotic transporter ABCG2 plays a novel role in differentiation of trophoblast-like BeWo cells. (17275084)
2007
24
Thyroid hormone receptor beta1 in normal colon and colorectal cancer-association with differentiation, polypoid growth type and K-ras mutations. (16231318)
2006
25
Mycobacterium marinum, a further infectious agent associated with sarcoidosis: the polyetiology hypothesis. (16449013)
2006
26
The replication factor C clamp loader requires arginine finger sensors to drive DNA binding and proliferating cell nuclear antigen loading. (16980295)
2006
27
Heterotrimeric G proteins in C. elegans. (18050432)
2006
28
Modulation of signal transducer and activator of transcription 5b activity in breast cancer cells by mutation of tyrosines within the transactivation domain. (16772534)
2006
29
Expression of vascular permeability factor in human vocal cord polyps]. (17144494)
2006
30
Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. (16859511)
2006
31
Screening for exonic copy number mutations at MSH2 and MLH1 by MAPH. (15951966)
2005
32
Dynamics of the interaction between the insulin receptor and protein tyrosine-phosphatase 1B in living cells. (12634852)
2003
33
Protein-protein interactions involving inducible nitric oxide synthase. (14510776)
2003
34
Deltex/Dtx mediates NOTCH signaling in regulation of Bmp4 expression in cranial neural crest formation during avian development. (12828685)
2003
35
Periorbital versus orbital cellulitis. (12488668)
2002
36
Expression of angiopoietin-1 and its receptor TEK in hematopoietic cells from patients with myeloid leukemia. (11755466)
2002
37
The cutaneous pathology associated with seropositivity for antibodies to SSA (Ro): a clinicopathologic study of 23 adult patients without subacute cutaneous lupus erythematosus. (10218672)
1999
38
Myocardial angiotensin receptors in human hearts. (9833160)
1998
39
Evaluating response to metrifonate. (9720485)
1998
40
Antenatal risk factors and neonatal outcome in meconium aspiration syndrome. (12348097)
1997
41
The Nuclear Receptor Resource Project. (9016529)
1997
42
C-terminal peptide of streptokinase, Met369-Pro373, is important in plasminogen activation. (8955883)
1996
43
Presynaptic inhibition of calcium-dependent and -independent release elicited with ionomycin, gadolinium, and alpha-latrotoxin in the hippocampus. (8734600)
1996
44
The majority of T lymphocytes are polyclonal during the chronic phase of chronic myelogenous leukemia. (8597608)
1996
45
Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells. (8765043)
1996
46
Role of phosphorylation in agonist-promoted beta 2-adrenergic receptor sequestration. Rescue of a sequestration-defective mutant receptor by beta ARK1. (7559596)
1995
47
Analysis of HLA-DR and -DQ gene polymorphisms in Sudanese patients with type 1 (insulin-dependent) diabetes. (1684174)
1991
48
Carcinoma of penis--role of phimosis. (6740858)
1984
49
Physical therapy in the acute care hospital and nursing home: treatment for patients with hemiplegia due to cerebrovascular accident. (103036)
1978
50
Urethral obstruction in the female child. (13583054)
1958

Variations for Atrophic Rhinitis

About this section

Expression for genes affiliated with Atrophic Rhinitis

About this section
Search GEO for disease gene expression data for Atrophic Rhinitis.

Pathways for genes affiliated with Atrophic Rhinitis

About this section

GO Terms for genes affiliated with Atrophic Rhinitis

About this section

Sources for Atrophic Rhinitis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet